Browse the evidence

The 'obesity paradox' in heart failure—where overweight/obese patients have better short-term outcomes than normal-weight patients—is likely confounded by unintentional weight loss from underlying diseases (like cancer) and lead-time bias, rather than being a true protective effect of obesity.

Do not rely on the 'obesity paradox' to avoid weight management. The idea that being overweight helps heart failure is likely a statistical error caused by sick people losing weight unintentionally. Intentional weight loss is associated with better clinical outcomes.

Providing free, convenient gym access to employees does not significantly improve weight loss outcomes compared to standard behavioral interventions, as gym usage remains low and weight loss is driven by the behavioral program rather than facility proximity.

Buying a gym membership or working near a gym will not automatically make you lose weight. In this study, people who worked near the gym used it more often, but they didn't lose more weight than those who didn't. Weight loss came from the behavioral program (diet/lifestyle coaching), not the gym access itself. Focus on the behavioral changes (diet, activity habits) rather than just buying access to facilities.

Current herbal anti-obesity clinical trials frequently fail to adhere to international pharmaceutical guidelines, particularly regarding study duration, lifestyle modifications, and safety monitoring.

When evaluating herbal weight loss studies, be aware that many do not follow the same rigorous standards as pharmaceutical trials. Look for studies that include lifestyle modifications, adequate duration, and safety monitoring, as these are often missing.

Off-label use of GLP-1 agonists by healthy athletes for aesthetic or performance purposes raises ethical, legal, and safety concerns, including potential classification as doping and inequality in sports access.

Using GLP-1 agonists off-label for aesthetic or performance reasons is not approved and carries ethical and legal risks. It may be viewed as doping and creates inequality in sports. Athletes should consult regulatory bodies and prioritize approved medical indications over off-label use for performance enhancement.

The Nutri-Score front-of-pack labeling system fails to identify unhealthy ultra-processed foods because it evaluates only nutrient composition and ignores the degree of food processing.

Do not rely solely on the Nutri-Score letter (A-E) to judge if a food is healthy. A product can receive an 'A' rating for nutrients but still be an ultra-processed food (NOVA 4) with additives and low nutritional value in terms of food matrix. Look for the degree of processing (NOVA classification) alongside or instead of Nutri-Score to make better choices.

A 6-month produce prescription program providing $60/month in vouchers for fruit and vegetables does not significantly improve glycemic control (HbA1c), blood pressure, or BMI in patients with diabetes compared to usual care.

For patients with diabetes, simply receiving vouchers for fruit and vegetables is not enough to lower blood sugar. To see health benefits, programs must ensure the voucher amount is sufficient for the patient's household size and include robust, ongoing nutritional education. Without these supports, financial incentives alone may fail to improve clinical outcomes.

The long-term mental health and quality of life benefits of an intensive lifestyle intervention (ILI) for type 2 diabetes do not persist after the intervention is terminated; participants revert to baseline risk levels comparable to a control group.

If you stop the structured support of a lifestyle program, your mental health and quality of life benefits will likely erate over time, even if you maintain some weight loss. To keep the psychological benefits, you need a long-term maintenance plan, not just an initial intensive phase.

Smoking is a significant risk factor that increases the risk of incident symptomatic peripheral arterial disease in individuals with diabetes mellitus.

If you smoke, quitting is critical for preventing peripheral arterial disease, especially if you have diabetes. This study shows that smokers have nearly twice the risk of developing PAD compared to non-smokers. Stopping smoking is the most impactful lifestyle change you can make to protect your circulation.

Standard, unvalidated diet quality (HEI-C) and fitness measures fail to correlate with clinical metabolic syndrome reversal, whereas factor-analytically derived latent models of these constructs demonstrate excellent measurement equivalence and validity.

If you are tracking diet or fitness progress to manage metabolic health, standard off-the-shelf scores (like basic HEI-C) may not accurately reflect your clinical improvements. To truly link your lifestyle changes to health outcomes, use validated, multi-component assessments that account for measurement error, rather than relying on single, unvalidated metrics.

The COVID-19 pandemic and associated mitigation strategies (e.g., stay-at-home orders, physical distancing) caused a significant increase in the prevalence of depressive symptoms and loneliness among older adults with type 2 diabetes, while insomnia prevalence remained stable.

If you are an older adult with diabetes, be aware that pandemic-related isolation can significantly worsen mood and loneliness. Monitor your mental health closely, as the risk is higher if you had prior symptoms. Prioritize safe social engagement strategies to mitigate these effects.

Obesity is a stigmatized condition where the desire for cosmetic weight loss often exceeds the desire for health benefits, leading to a mismatch between patient expectations and clinical outcomes, which negatively affects treatment adherence and drug regulation.

Understand that your desire to look different is normal, but clinical weight loss is slow and modest. Health benefits happen at lower weight loss levels than cosmetic changes. Focus on how you feel and your health markers (blood pressure, blood sugar) rather than just the scale number to stay motivated.

Extending traditional behavioral weight loss therapy from 20 weeks to 52 weeks does not significantly increase total weight loss, as the majority of loss occurs in the first 20-26 weeks and plateaus thereafter.

Don't expect your weight loss to continue at the same rate if you stay in a program for a year. Most of the loss happens in the first 6 months. If you aren't losing weight after 6 months, extending the program duration is unlikely to help significantly.

Adding personalized e-feedback and reminder calls to a basic commercial web-based weight loss program does not result in greater weight loss or BMI reduction compared to the basic program alone after 12 weeks.

You do not need to pay for enhanced features like personalized feedback or reminder calls to lose weight. The basic program is sufficient for weight loss. Enhanced features might help you stay in the program longer, but they won't make you lose more weight in the first 12 weeks.

Mobile phone interventions for type 2 diabetes do not significantly improve HbA1c levels compared to control groups, although they may improve self-management skills when combined with health counseling.

Using a mobile app to track your diabetes may not significantly lower your HbA1c on its own. However, combining it with health counseling can improve your self-management skills. Focus on using the app consistently and seeking support.

Obesity spreads through social networks via interpersonal induction, where a person's risk of becoming obese increases significantly if their friends, siblings, or spouses become obese, independent of geographic proximity.

Your social circle matters for your weight. If your close friends or family members gain weight, your own risk of gaining weight increases, likely due to shifting norms and shared behaviors. To maintain a healthy weight, consider how your social network influences your habits and seek supportive relationships that align with your health goals.

Systematic undertreatment of hypertension, hypercholesterolemia, and diabetes in patients with atherothrombosis leads to elevated cardiovascular risk profiles globally, regardless of geographic region.

If you have heart disease or high risk, simply being 'on medication' is not enough. You must verify that your blood pressure, cholesterol, and blood sugar are actually within target ranges. If they are not, your treatment is likely insufficient, regardless of how many pills you take. Seek a review of your specific numbers against guideline targets.

Health-related stigma acts as a global barrier that impedes health-seeking behavior, engagement in care, and adherence to treatment across various conditions.

Health stigma is a major, documented barrier to getting care and sticking to treatment plans. It operates through social, cultural, and structural forces, not just individual psychology. To improve health outcomes, interventions must address these multi-level drivers rather than focusing solely on individual coping.

Preoperative identification of Obstructive Sleep Apnea (OSA) via clinical criteria improves perioperative outcomes by enabling tailored airway management, even in the absence of formal sleep studies.

If you have risk factors for sleep apnea (high BMI, large neck, snoring), tell your anesthesiologist before surgery. This allows them to prepare for potential airway issues, significantly reducing your risk of complications, even if you feel healthy.

CPAP therapy for obstructive sleep apnea requires different minimum nightly durations to normalize subjective sleepiness (4 hours), objective sleepiness (6 hours), and functional status (7.5 hours).

If you use CPAP for sleep apnea, 'enough' depends on what you want to fix. To feel less sleepy, 4 hours might be enough. To feel less sleepy objectively, aim for 6 hours. To fully restore your daily functioning and quality of life, you likely need 7.5 hours. Consistency is key; skipping nights reverses benefits.

Higher BMI is associated with a higher frequency of experiencing weight stigma, particularly from family members.

As your weight increases, you are statistically more likely to experience stigma, especially from family. This is a societal issue, not a reflection of your character. Being aware of this pattern can help you anticipate and manage these interactions.

There is a massive gap between objective sleep apnea severity and clinical diagnosis, with 84-93% of individuals with moderate-to-severe SDB remaining undiagnosed across all racial groups.

Do not rely on a doctor's diagnosis to rule out sleep apnea. If you have risk factors (race, obesity, snoring), seek objective testing, as the vast majority of moderate-to-severe cases go undiagnosed.

High levels of physical activity are associated with a 27% increased risk of melanoma, likely due to increased outdoor sun exposure rather than the activity itself.

If you exercise outdoors, prioritize sun safety. Use sunscreen, wear protective clothing, and seek shade when possible to mitigate the increased risk of melanoma associated with outdoor physical activity.

Disadvantaged populations (low SES, Black, Hispanic) are disproportionately exposed to obesogenic built environment characteristics, including fewer supermarkets, more convenience stores, and less safety.

Public health efforts must recognize that disadvantaged neighborhoods often lack basic infrastructure for health. Solutions require targeted investment in these specific areas to correct the imbalance in food and exercise access.

Exposure to dim light at night (≥5 lux) increases body mass and impairs glucose tolerance in nocturnal rodents by shifting the timing of food intake to the inactive light phase, despite total caloric intake remaining unchanged.

If you are exposed to light at night (e.g., bedroom lights, screens), try to avoid eating during those hours. Even if you don't eat more total food, eating at the 'wrong' time (when you should be sleeping) can lead to weight gain and poorer blood sugar control. Align your eating window with your active, light-exposed hours.